Atlas Trials

BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis

Clinical trial NCT02430532 · TERMINATED

Trial details

NCT number
NCT02430532
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Sclerosis, Secondary Progressive
Start date
2015-05-01
Primary completion
2016-01-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.